Clinical trial
Docetaxel in Treating Older Patients With Metastatic Breast, Lung, or Prostate…
NCT00059943 · Memorial Sloan Kettering Cancer Center, Other · Completed
Key facts
| NCT number | NCT00059943 |
|---|---|
| Title | Docetaxel in Treating Older Patients With Metastatic Breast, Lung, or Prostate Cancer |
| Official title | Pharmacokinetics of Weekly Docetaxel in Patients Age 65 and Older With Metastatic Breast or Lung Cancer |
| Lead sponsor | Memorial Sloan Kettering Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer, Lung Cancer, Prostate Cancer |
| Intervention type | Drug |
| Interventions | docetaxel |
| Start date | Sep 1, 2002 |
| Primary completion | Sep 1, 2005 |
| First posted | May 7, 2003 |
| Last update posted | Jan 16, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: